About
SpyGlass Pharma develops sustained drug delivery technology integrated with cataract surgery to treat glaucoma and other chronic eye diseases by providing long-acting intraocular pressure control.
Explore SpyGlass Pharma, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.